| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |